An LSTM-Based Time-Series Framework for Early Detection of Prostatitis Using Longitudinal Clinical Indicators
DOI:
https://doi.org/10.62054/ijdm/0301.15Abstract
Prostatitis, a prevalent urological condition among men, often remains undetected in its early stages due to subtle or overlapping symptoms. This research suggests a method based on deep learning for early detection, utilizing clinically generated synthetic data. A dataset comprising 120 patients with prostate-specific antigen (PSA) levels and other haematological parameters was pre-processed and modeled using a Long Short-Term Memory (LSTM) neural network. The model demonstrated outstanding classification performance, achieving an accuracy of 98.5%, precision of 97.6%, recall of 98.2%, F1 score of 97.9%, and an AUC of 0.992, confirming its robustness and high discriminative capability. Evaluation through The model’s reliability in differentiating between prostatitis and non-prostatitis cases was further confirmed by the confusion matrix and ROC curve. These results affirm the potential of LSTM-based models in supporting clinical diagnosis, particularly where access to real patient data is limited. The study contributes a scalable and ethical diagnostic framework adaptable to similar medical prediction tasks and recommends future validation using real clinical datasets such as electronic health records (EHRs) to enhance generalizability and real-world applicability.
References
Bozeman, C. B., Carver, B. S., Eastham, J. A., & Venable, D. D. (2002). Treatment of chronic prostatitis lowers serum prostate specific antigen. The Journal of Urology, 167(4), 1723–1726. https://doi.org/10.1016/S0022-5347(05)65188-2
Che, Z., Purushotham, S., Cho, K., Sontag, D., & Liu, Y. (2018). Recurrent neural networks for multivariate time series with missing values. Scientific Reports, 8(1), 6085. https://doi.org/10.1038/s41598-018-24271-9
Filella, X., & Giménez, N. (2013). Evaluation of inflammatory prostate diseases: PSA and other biomarkers. Urologia Internationalis, 90(2), 123–130. https://doi.org/10.1159/000343758
He, H., Luo, H., Xu, H., Qian, B., Zou, X., Zhang, G., Zeng, F., & Zou, J. (2023). Preclinical models and evaluation criteria of prostatitis. Frontiers in Immunology, 14, 1183895. https://doi.org/10.3389/fimmu.2023.1183895
Hochreiter, S., & Schmidhuber, J. (1997). Long short-term memory. Neural Computation, 9(8), 1735–1780. https://doi.org/10.1162/neco.1997.9.8.1735
Maeda, K., Mizuno, K., Murakami, S., & Sakata, O. (2023). A review of current treatments for chronic prostatitis: What’s new? International Journal of Urology, 30(4), 302–314. https://doi.org/10.1111/iju.15149
Nickel, J. C., Downey, J., Hunter, D., & Clark, J. (2001). Prevalence of prostatitis-like symptoms in a population-based study. The Journal of Urology, 165(3), 842–845.
Pendegast, H. J., Leslie, S. W., & Rosario, D. J. (2025). Chronic prostatitis and chronic pelvic pain syndrome in men. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK599550/
Razavian, N., Marcus, J., & Sontag, D. (2016). Multi-task prediction of disease onsets from longitudinal lab tests. arXiv. https://arxiv.org/abs/1608.00647
Sushentsev, N., et al. (2023). Predicting prostate cancer progression using LSTM applied to PSA and MRI series. European Urology Focus, 9(1), 112–121.
World Health Organization. (2021). Primary health care systems and diagnostics in developing countries. WHO Technical Report Series. https://www.who.int.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aisha. A. Daware, Asabe. S. Ahmadu, Hamza Abdullahi (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are solely responsible for obtaining permission to reproduce any copyrighted material contained in the manuscript as submitted. Any instance of possible prior publication in any form must be disclosed at the time the manuscript is submitted and a
copy or link to the publication must be provided.
The Journal articles are open access and are distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs 4.0 IGO License, which permits use,
distribution, and reproduction in any medium, provided the original work is properly cited.
No modifications or commercial use of the articles are permitted.




